Markets
Borrow
Earn
Invest
Private
Security
Newsroom
More
Log In
Sign Up
Markets
Market Overview
Indices and commodities.
Digital Credit
Bitcoin treasury preferreds.
AI Stocks
The artificial intelligence theme.
Bitcoin Treasuries
Companies holding bitcoin.
Economy
Sectors, global markets and rates.
Popular Portfolios
13F filings, smart money.
Borrow
Borrow
Borrow USDT or USDC against your BTC without giving it up.
ReFi
Switch your bitcoin-backed loan and pay less interest.
Earn
Carry Trade
Borrow, invest, keep the spread.
Stock Dividends
Dividends from tokenized equities.
Invest
Private
Security
Newsroom
More
Company
About Us
Our leadership team, mission, and investors.
Whitepaper
Vision, purpose, and architecture behind Roxom.
Legal
Terms, privacy, and disclosures.
Resources
Help Center
Guides, FAQs & support.
Rulebook
Trading logic, platform rules, and fundamentals.
API Docs
Connect, authenticate, and build with our API.
Status
Current platform health and incidents.
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
1 BTC
=
- USD
BTC
SATS
Loading market data...
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
RG
Regencell Bioscience Holdings Limited Ordinary Shares
RGC
Mkt Cap
$4.75B
Volume
664.68K
Next Earnings
October 30th
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
RG
RGC
RG
Regencell Bioscience Holdings Limited Ordinary Shares
RGC
News
·
DEADLINE ALERT for LKQ, RGC, and GLOB: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
Mkt Cap
$4.72B
Volume
664.68K
Next Earnings
October 30th
Chart
Financials
Earnings
News
About
Insider
Filings
DEADLINE ALERT for LKQ, RGC, and GLOB: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
Class action lawsuits have been filed against LKQ Corporation, Regencell Bioscience Holdings Limited, and Globant S.A. The complaints allege that defendants made materially false and misleading statements and failed to disclose material adverse facts about their businesses. LKQ faced issues with FinishMaster losing major customers post-acquisition, Regencell was vulnerable to market manipulation, and Globant faced decreasing demand in Latin America with frozen wages.
GlobeNewswire Inc. · Jun 22, 2026
FSK DEADLINE NOTICE: ROSEN, A RANKED AND LEADING FIRM, Encourages FS KKR Capital Corp. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – FSK
Rosen Law Firm has announced securities class action lawsuits against FS KKR Capital Corp. (FSK), Regencell Bioscience Holdings Limited (RGC), and Microsoft (MSFT). The FSK lawsuit alleges the company made false statements regarding portfolio restructuring effectiveness, investment valuations, and distribution strategy durability. Investors with losses exceeding $100K are encouraged to join the class action before the July 6, 2026 deadline for FSK and June 23, 2026 for RGC.
GlobeNewswire Inc. · Jun 22, 2026
REGENCELL DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Regencell Bioscience Holdings Limited Investors with Losses in Excess of $100K to Secure Counsel Before Important June 23 Deadline in Securities Class Action – RGC
Rosen Law Firm is encouraging investors with losses exceeding $100,000 in Regencell Bioscience Holdings Limited, FS KKR Capital Corp., and Microsoft to join securities class action lawsuits. The firm has set a June 23, 2026 deadline for lead plaintiff claims. The lawsuits allege that defendants made false or misleading statements regarding market manipulation vulnerabilities and regulatory risks.
GlobeNewswire Inc. · Jun 22, 2026
RGC UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Regencell Bioscience (RGC) Investors of Securities Class Action Lawsuit Deadline on June 23, 2026
Faruqi & Faruqi, LLP is reminding investors in Regencell Bioscience Holdings Limited (RGC) of the June 23, 2026 deadline to seek lead plaintiff status in a federal securities class action. The lawsuit alleges that Regencell and its executives made false and misleading statements by concealing the company's vulnerability to market manipulation and the resulting regulatory risks. The DOJ investigation was disclosed on October 31, 2025, causing RGC's share price to fall 18.56% on November 3, 2025.
GlobeNewswire Inc. · Jun 21, 2026
SRAD IMPORTANT DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Sportradar Group AG Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - SRAD
Rosen Law Firm has issued multiple securities class action deadline alerts for investors. The primary case involves Sportradar Group AG (SRAD), where investors who purchased shares between November 7, 2024 and April 21, 2026 may be entitled to compensation. The lawsuit alleges that Sportradar made false statements about compliance and worked with black-market gambling operators while claiming strict regulatory adherence. The lead plaintiff deadline is July 17, 2026. Similar deadline alerts were also issued for FS KKR Capital Corp. (FSK) and Regencell Bioscience Holdings Limited (RGC).
GlobeNewswire Inc. · Jun 18, 2026
REGENCELL DEADLINE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Regencell Bioscience Holdings Limited Investors with Losses in Excess of $100K to Secure Counsel Before Important June 23 Deadline in Securities Class Action – RGC
Rosen Law Firm is reminding investors in Regencell Bioscience Holdings Limited (RGC) and AeroVironment, Inc. (AVAV) of upcoming lead plaintiff deadlines in securities class action lawsuits. The lawsuits allege that defendants made false or misleading statements regarding market manipulation vulnerabilities, regulatory risks, and financial exposure during their respective class periods.
GlobeNewswire Inc. · Jun 18, 2026
Pomerantz Law Firm Announces the Filing of a Class Action Against Regencell Bioscience Holdings Limited and Certain Officers – RGC
Pomerantz LLP filed a class action lawsuit against Regencell Bioscience Holdings Limited for alleged securities fraud. The lawsuit covers investors who purchased shares between October 28, 2024 and October 31, 2025. Regencell's stock experienced extreme volatility, surging to $78 per share in June 2025 before collapsing, with no corresponding business fundamentals. The company received a DOJ subpoena investigating trading in its ordinary shares, which triggered an 18.56% stock price decline upon disclosure.
GlobeNewswire Inc. · Jun 16, 2026
RGC DEADLINE ALERT: ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Regencell Bioscience Holdings Limited Investors with Losses in Excess of $100K to Secure Counsel Before Important June 23 Deadline in Securities Class Action – RGC
Rosen Law Firm announces securities class action lawsuits against Regencell Bioscience Holdings Limited, Sportradar Group AG, and TruBridge, Inc. Investors with losses exceeding $100,000 are encouraged to join the litigation before the June 23, 2026 deadline. The lawsuits allege false and misleading statements regarding market manipulation, regulatory risks, and undisclosed material information.
GlobeNewswire Inc. · Jun 16, 2026
Bronstein, Gewirtz & Grossman LLC Urges Regencell Bioscience Holdings Ltd. Investors to Act: Class Action Filed Alleging Investor Harm
A class action lawsuit has been filed against Regencell Bioscience Holdings Ltd. (NASDAQ: RGC) alleging that company defendants made materially false and misleading statements regarding the company's business operations and compliance policies. The lawsuit claims Regencell was vulnerable to market manipulation and failed to disclose associated risks to investors. The class period covers purchases between October 28, 2024 and October 31, 2025, with a lead plaintiff deadline of June 23, 2026.
GlobeNewswire Inc. · Jun 14, 2026
RGC EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Regencell Bioscience (RGC) Investors of Securities Class Action Lawsuit Deadline on June 23, 2026
A federal securities class action has been filed against Regencell Bioscience Holdings Limited (NASDAQ: RGC) alleging that the company and its executives made false and misleading statements by concealing vulnerability to market manipulation and regulatory risks. The DOJ launched an investigation into trading in RGC's ordinary shares, disclosed on October 31, 2025, causing the stock to fall 18.56%. Investors who purchased RGC securities between October 28, 2024 and October 31, 2025 may be eligible to participate in the lawsuit, with a June 23, 2026 deadline to seek lead plaintiff appointment.
GlobeNewswire Inc. · Jun 13, 2026
Holdings
Open Orders (0)
Positions (0)
Order History
Dividends
Transfers
Log In
to start trading
RG
RGC
Regencell Bioscience Holdings Limited Ordinary Shares
Buy
Sell
Market
Limit
Soon
RGC
25%
50%
75%
Max
Pay with
—
Start Trading
Available Balance
0.00
Your Position
You don't own any RGC yet.
Related Tickers
Earnings